Monopar Expands Phase 2b/3 VOICE Clinical Trial to Europe

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/14/2026

1. JPM
2. SPY
3. WFC
4. ERAS
5. IBM
6. BAC
7. TREX
8. SPRO
9. AAPL
10. GS

Go back to Monopar Expands Phase 2b/3 VOICE Clinical Trial to Europe
(NASDAQ: MNPR) Delayed: 103.33 --0 (-0%)
Previous Close $103.33    52 Week High $ 
Open $103.33    52 Week Low $ 
Day High $103.33    P/E N/A 
Day Low $103.33    EPS $ 
Volume 7,720